Zdrowie i gospodarka · 29/08/1995

FDA Approves IPR Pharmaceuticals' Request to Export Atenolol Bulk Drug Substance to France

The Food and Drug Administration (FDA) is announcing that IPR Pharmaceuticals, Inc., a part of Zeneca Group PLC, has filed a request with the FDA to export the bulk drug substance Atenolol to France to manufacture approved finished formulations containing Atenolol.